Hainan Poly Pharm Co (SZSE:300630) Operating Cash Flow per Share : ¥0.88 (TTM As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Hainan Poly Pharm Co Operating Cash Flow per Share?

Hainan Poly Pharm Co's operating cash flow per share for the three months ended in Sep. 2023 was ¥-0.09. Hainan Poly Pharm Co's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2023 was ¥0.88.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Hainan Poly Pharm Co was 388.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 31.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 31.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 21.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Hainan Poly Pharm Co's Operating Cash Flow per Share or its related term are showing as below:

SZSE:300630' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 6.7 Med: 14.95 Max: 47.5
Current: 31

During the past 11 years, Hainan Poly Pharm Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 47.50% per year. The lowest was 6.70% per year. And the median was 14.95% per year.

SZSE:300630's 3-Year OCF Growth Rate is ranked better than
77.25% of 800 companies
in the Drug Manufacturers industry
Industry Median: 6.9 vs SZSE:300630: 31.00

Hainan Poly Pharm Co Operating Cash Flow per Share Historical Data

The historical data trend for Hainan Poly Pharm Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Poly Pharm Co Operating Cash Flow per Share Chart

Hainan Poly Pharm Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.23

0.51

0.76

0.36

1.14

Hainan Poly Pharm Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.03	0.81	0.07	0.08	-0.09

Competitive Comparison of Hainan Poly Pharm Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow falls into.

Hainan Poly Pharm Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Hainan Poly Pharm Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	534.295	/	467.351
	=	1.14

Hainan Poly Pharm Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Sep. 2023 )	=	Cash Flow from Operations (Q: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2023 )
	=	-43.107	/	479.838
	=	-0.09

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.88

Hainan Poly Pharm Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Hainan Poly Pharm Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Poly Pharm Co (SZSE:300630) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Poly Pharm Co Ltd (SZSE:300630) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

No.1509 Binsheng Road, 10th Floor, Zhejiang Province, Hangzhou, CHN, 310051

Website

http://www.hnpoly.com

Hainan Poly Pharm Co Ltd is a pharmaceutical manufacturer in China. It manufactures injections, oral solid formulations, dry suspension, and other active pharmaceutical ingredients. The products offered by the company include Azithromycin for Injection, Ganciclovir Sodium for Injection. Octreotide Acetate Injection, Trimebutine Maleate tablets, Desloratadine, Trimebutine Maleate, and GANCICLOVIR among others.

Executives

Fan De Zhu	Independent director
Xie Hui Fang	Supervisors
Pu Jian	Executives
Xu Zhao	Securities Affairs Representative
Shen Shi Hua	Executives
Zhou Mao	Directors, Directors, and Executives

Hainan Poly Pharm Co (SZSE:300630) Headlines

No Headlines